AI assistant
Antero Midstream Corp — Director's Dealing 2021
Dec 7, 2021
30647_dirs_2021-12-06_ebc3ef24-0baf-48ac-ae7d-ae5d6e64f0ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Antero Midstream Corp (AM)
CIK: 0001623925
Period of Report: 2021-12-02
Reporting Person: Keenan W Howard JR (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-02 | Common stock, par value $0.01 per share | J | 4609 | — | Acquired | 88949 | Direct |
| 2021-12-02 | Common stock, par value $0.01 per share | J | 8510 | — | Acquired | 97459 | Direct |
| 2021-12-02 | Common stock, par value $0.01 per share | J | 736866 | — | Disposed | 1272768 | Indirect |
| 2021-12-02 | Common stock, par value $0.01 per share | J | 1205973 | — | Disposed | 1964012 | Indirect |
Footnotes
F1: Pro rata distributions from Yorktown Energy Partners VII, L.P. ("Yorktown VII"), Yorktown VII Company LP ("Yorktown VII Company") and Yorktown VII Associates LLC ("Yorktown VII Associates").
F2: Pro rata distributions from Yorktown Energy Partners VIII, L.P. ("Yorktown VIII"), Yorktown VIII Company LP ("Yorktown VIII Company") and Yorktown VIII Associates LLC ("Yorktown VIII Associates").
F3: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purpose.
F4: These securities are owned directly by Yorktown VII. The reporting person is a member and manager of Yorktown VII Associates, the general partner of Yorktown VII Company, the general partner of Yorktown VII.
F5: These securities are owned directly by Yorktown VIII. The reporting person is a member and manager of Yorktown VIII Associates, the general partner of Yorktown VIII Company, the general partner of Yorktown VIII.